Fortis Capital Management LLC Biogen Inc. Transaction History

Fortis Capital Management LLC

  • $495 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$264.77 - $305.71 $215,522 - $248,847
-814 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$258.66 - $342.55 $7,501 - $9,933
-29 Reduced 3.44%
814 $218,000
Q1 2020

May 14, 2020
SELL
$268.85 - $341.04 $15,055 - $19,098
-56 Reduced 6.23%
843 $267,000
Q4 2019

Feb 14, 2020
BUY
$220.06 - $304.07 $197,833 - $273,358
899 New
899 $267,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Fortis Capital Management LLC Portfolio

Follow Fortis Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email